Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01008150
Title Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors NSABP Foundation Inc
Indications

breast cancer

Therapies

Cyclophosphamide + Doxorubicin + Neratinib + Paclitaxel + Trastuzumab

Cyclophosphamide + Doxorubicin + Paclitaxel + Trastuzumab

Cyclophosphamide + Doxorubicin + Neratinib + Paclitaxel

Age Groups: adult
Covered Countries USA | ITA | ESP | CAN


No variant requirements are available.